Jazz Pharmaceuticals (Germany) Probability of Future Stock Price Finishing Under 99.52
| J7Z Stock | EUR 119.00 0.15 0.13% |
Jazz |
Jazz Pharmaceuticals Target Price Odds to finish below 99.52
The tendency of Jazz Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 99.52 or more in 90 days |
| 119.00 | 90 days | 99.52 | about 12.56 |
Based on a normal probability distribution, the odds of Jazz Pharmaceuticals to drop to € 99.52 or more in 90 days from now is about 12.56 (This Jazz Pharmaceuticals plc probability density function shows the probability of Jazz Stock to fall within a particular range of prices over 90 days) . Probability of Jazz Pharmaceuticals plc price to stay between € 99.52 and its current price of €119.0 at the end of the 90-day period is about 76.56 .
Assuming the 90 days horizon Jazz Pharmaceuticals has a beta of 0.19. This indicates as returns on the market go up, Jazz Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Jazz Pharmaceuticals plc will be expected to be much smaller as well. Additionally Jazz Pharmaceuticals plc has an alpha of 0.3118, implying that it can generate a 0.31 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Jazz Pharmaceuticals Price Density |
| Price |
Predictive Modules for Jazz Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Jazz Pharmaceuticals plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Jazz Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Jazz Pharmaceuticals is not an exception. The market had few large corrections towards the Jazz Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Jazz Pharmaceuticals plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Jazz Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.31 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 8.18 | |
Ir | Information ratio | 0.15 |
Jazz Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Jazz Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Jazz Pharmaceuticals plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company has €6.02 Billion in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 3.09 B. Net Loss for the year was (329.67 M) with profit before overhead, payroll, taxes, and interest of 2.88 B. | |
| Over 93.0% of the company shares are owned by institutional investors |
Jazz Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Jazz Stock often depends not only on the future outlook of the current and potential Jazz Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jazz Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 61.4 M |
Jazz Pharmaceuticals Technical Analysis
Jazz Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Jazz Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Jazz Pharmaceuticals plc. In general, you should focus on analyzing Jazz Stock price patterns and their correlations with different microeconomic environments and drivers.
Jazz Pharmaceuticals Predictive Forecast Models
Jazz Pharmaceuticals' time-series forecasting models is one of many Jazz Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Jazz Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Jazz Pharmaceuticals plc
Checking the ongoing alerts about Jazz Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Jazz Pharmaceuticals plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company has €6.02 Billion in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 3.09 B. Net Loss for the year was (329.67 M) with profit before overhead, payroll, taxes, and interest of 2.88 B. | |
| Over 93.0% of the company shares are owned by institutional investors |
Additional Information and Resources on Investing in Jazz Stock
When determining whether Jazz Pharmaceuticals plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock:Check out Jazz Pharmaceuticals Backtesting, Jazz Pharmaceuticals Valuation, Jazz Pharmaceuticals Correlation, Jazz Pharmaceuticals Hype Analysis, Jazz Pharmaceuticals Volatility, Jazz Pharmaceuticals History as well as Jazz Pharmaceuticals Performance. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.